A Study to Evaluate the Effect of Romosozumab (AMG 785) on Bone Quality of the Forearm in Postmenopausal Women With Low Bone Mass
Clinical trial NCT00950950 · COMPLETED
Trial details
- NCT number
- NCT00950950
- Sponsor
- Amgen
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2009-08-18
- Primary completion
- 2010-08-19
- Enrollment
- 24
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.